Biological Therapy Analysis & Statistics, December 2014

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

All regions

You might be interested in: Flow Cytometry, Hematology, Stem Cell, more »

1-30 of about 400 reports

Purchase Reports From Reputable Market Research Publishers

Analysis of the Global Stem Cell Market

Analysis of the Global Stem Cell Market

  • $ 6 000
  • Industry report
  • October 2014
  • by Frost & Sullivan

The key to Transforming Future of Diagnostic and Therapeutic Medicine This study investigates the global stem cell market for the period 2013 to 2018. The geographic regions covered in the study are the ...

  • Industries : Biological Therapy
  • Countries : South Korea, World, Singapore, Australia, Malaysia, Thailand, Asia, Japan, India
NDDS in Cancer Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020

NDDS in Cancer Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020

  • $ 4 795
  • Industry report
  • October 2014
  • by Transparency Market Research

This study on novel drug delivery systems (NDDS) in cancer therapy comprises study of technologies such as embolization devices, liquid embolics and nanoparticles that offer unique approaches in cance ...

  • Industries : Biological Therapy
  • Countries : World
Cell Expansion Market by Product (Reagent, Media, Serum, Bioreactors, Centrifuge), Cell Type (human, animal), Application (Stem Cell Research, Regenerative Medicine, Clinical Diagnostics), End User (Hospital, Biotechnology, Cell Bank) - Forecast to 2019

Cell Expansion Market by Product (Reagent, Media, Serum, Bioreactors, Centrifuge), Cell Type (human, animal), Application (Stem Cell Research, Regenerative Medicine, Clinical Diagnostics), End User (Hospital, Biotechnology, Cell Bank) - Forecast to 2019

  • $ 4 650
  • Industry report
  • October 2014
  • by MarketsandMarkets

The global cell expansion market is expected to reach $14.8 billion by 2019 from $6.0 billion in 2014, growing at a CAGR of 19.7% from 2014 to 2019. The global cell expansion market is categorized on the ...

  • Industries : Biological Therapy
  • Countries : World
Cell Isolation/Cell Separation Market by Product (Reagent, Media, Bead, centrifuge), Cell Type (human, stem cell, animal), Technique (Filtration, Surface Marker), Application (Research, IVD) & by End user (Hospital, Biotechnology) - Forecast to 2019

Cell Isolation/Cell Separation Market by Product (Reagent, Media, Bead, centrifuge), Cell Type (human, stem cell, animal), Technique (Filtration, Surface Marker), Application (Research, IVD) & by End user (Hospital, Biotechnology) - Forecast to 2019

  • $ 4 650
  • Industry report
  • September 2014
  • by MarketsandMarkets

The global cell isolation market is expected to reach $5.1 billion by 2019 from $2.5 billion in 2014, growing at a CAGR of 15.8% from 2014 to 2019. The global cell isolation market is categorized on the ...

  • Industries : Biological Therapy
  • Countries : World, Europe, North America
Cell Line Development Market by Product (Equipment, Media and Reagents), Source, type & by Application ( Bioproduction, Tissue Engineering & Regenerative medicine, Toxicity Testing, Research, Drug Discovery) - Analysis & Global Forecast to 2019

Cell Line Development Market by Product (Equipment, Media and Reagents), Source, type & by Application ( Bioproduction, Tissue Engineering & Regenerative medicine, Toxicity Testing, Research, Drug Discovery) - Analysis & Global Forecast to 2019

  • $ 4 650
  • Industry report
  • September 2014
  • by MarketsandMarkets

Over the years, the cell line development market has witnessed various technological advancements in order to cater to the growing demand for stable and high-yielding cell lines. These advancements have ...

  • Industries : Biological Therapy
  • Countries : World
Immunotherapy in Oncology: Drug Pathway Analyzer 2014

Immunotherapy in Oncology: Drug Pathway Analyzer 2014

  • $ 3 675
  • Industry report
  • November 2014
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 881 immunotherapy drugs known to affect more than 235 specific intracellular signaling pathways for the ...

  • Industries : Biological Therapy
Immunotherapy in Oncology Drug Pipeline Update 2014

Immunotherapy in Oncology Drug Pipeline Update 2014

  • $ 3 675
  • Industry report
  • October 2014
  • by Bioseeker

Cancer immunotherapy offers an attractive therapeutic addition, delivering treatment of high specificity, low toxicity and prolonged activity. In this Drug Pipeline Update BioSeeker brings together the ...

  • Industries : Biological Therapy
PharmaSphere: Emerging Biotechnologies - Stem Cell Therapy

PharmaSphere: Emerging Biotechnologies - Stem Cell Therapy

  • $ 2 995
  • Industry report
  • November 2014
  • by Global Data

PharmaSphere: Emerging Biotechnologies - Stem Cell Therapy Summary GlobalData's report "PharmaSphere: Emerging Biotechnologies - Stem Cell Therapy", provides strategic analysis of the global stem cells ...

  • Industries : Biological Therapy
  • Countries : United States, South Korea, Japan, India, China, Asia, World
Global miRNA Market 2015-2019

Global miRNA Market 2015-2019

  • $ 2 500
  • Industry report
  • November 2014
  • by Infiniti Research Limited

About miRNAs miRNAs are single-stranded, small, non-coding RNA molecules that regulate gene expression at the translation level. They play a vital role in research, diagnostics, and therapeutics to study ...

  • Industries : Biological Therapy
  • Countries : World
Retinitis Pigmentosa (Retinitis) - Pipeline Review, H2 2014

Retinitis Pigmentosa (Retinitis) - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • November 2014
  • by Global Markets Direct

Retinitis Pigmentosa (Retinitis) - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Retinitis Pigmentosa (Retinitis) - Pipeline Review, H2 2014', provides an overview of the Retinitis Pigmentosa ...

  • Industries : Biological Therapy
Critical Limb Ischemia - Pipeline Review, H2 2014

Critical Limb Ischemia - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • November 2014
  • by Global Markets Direct

Critical Limb Ischemia - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Critical Limb Ischemia - Pipeline Review, H2 2014', provides an overview of the Critical Limb Ischemia's therapeutic ...

  • Industries : Biological Therapy
  • Countries : World
Degenerative Disc Disease - Pipeline Review, H2 2014

Degenerative Disc Disease - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • November 2014
  • by Global Markets Direct

Degenerative Disc Disease - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Degenerative Disc Disease - Pipeline Review, H2 2014', provides an overview of the Degenerative Disc Disease's therapeutic ...

  • Industries : Biological Therapy
  • Countries : World
Age Related Macular Degeneration - Pipeline Review, H2 2014

Age Related Macular Degeneration - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • October 2014
  • by Global Markets Direct

Age Related Macular Degeneration - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Age Related Macular Degeneration - Pipeline Review, H2 2014', provides an overview of the Age Related Macula ...

  • Industries : Biological Therapy
Hematopoietic Stem Cell Transplantation - Pipeline Review, H2 2014

Hematopoietic Stem Cell Transplantation - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • October 2014
  • by Global Markets Direct

Hematopoietic Stem Cell Transplantation - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Hematopoietic Stem Cell Transplantation - Pipeline Review, H2 2014', provides an overview of the Hematopoietic ...

  • Industries : Biological Therapy
  • Countries : World
Gene Therapy Partnering Terms and Agreements

Gene Therapy Partnering Terms and Agreements

  • $ 1 995
  • Industry report
  • December 2014
  • by Currentpartnering

The Gene Therapy Partnering Agreements report provides an understanding and access to the gene therapy partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in ...

  • Industries : Biological Therapy
Androgen Receptor Signaling Pathway in Oncology Drug Pipeline Update 2014

Androgen Receptor Signaling Pathway in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • October 2014
  • by Bioseeker

The androgen receptor signaling pathway activates the SMAD signaling module. There are today 329 companies plus partners developing 445 Androgen Receptor drugs in 1531 developmental projects in cancer. ...

  • Industries : Biological Therapy
B Cell Receptor Signaling Pathway in Oncology Drug Pipeline Update 2014

B Cell Receptor Signaling Pathway in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • October 2014
  • by Bioseeker

Activation of the B cell receptor involves phosphorylation of the cytoplasmic immunoreceptor tyrosine-based activation motifs (ITAMs) present in Ig alpha and beta. This leads to activation of several non-recepto ...

  • Industries : Biological Therapy
Targeting Immune Checkpoints in Cancer Immunotherapy Drug Pipeline Update 2014

Targeting Immune Checkpoints in Cancer Immunotherapy Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • October 2014
  • by Bioseeker

BioSeeker's Targeting Immune Checkpoints in Cancer Immunotherapy: Drug Pipeline Update is the most up to date and comprehensive pipeline review and competitive assessment you can get on this hot and fast ...

  • Industries : Biological Therapy
Gene Therapy in Oncology Drug Pipeline Update 2014

Gene Therapy in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • October 2014
  • by Bioseeker

There are today 120 companies plus partners developing 106 gene therapy drugs in 283 developmental projects in cancer. In addition, there are 4 suspended drugs and the accumulated number of ceased drugs ...

  • Industries : Biological Therapy
EGFR1 Signaling Pathway in Oncology Drug Pipeline Update 2014

EGFR1 Signaling Pathway in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • October 2014
  • by Bioseeker

The EGFR1 signaling pathway activates the Ras/Raf/MAPK signaling modules. There are today 371 companies plus partners developing 654 EGFR1 pathway targeting drugs in 2522 developmental projects in cancer. ...

  • Industries : Biological Therapy
Hedgehog Signaling Pathway in Oncology Drug Pipeline Update 2014

Hedgehog Signaling Pathway in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • October 2014
  • by Bioseeker

Aberrant activation of the Hedgehog pathway has been associated with a number of human malignancies including carcinoma of lung, esophagus, pancreas and prostate. There are today 119 companies plus partners ...

  • Industries : Biological Therapy
Notch Signaling Pathway in Oncology Drug Pipeline Update 2014

Notch Signaling Pathway in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • October 2014
  • by Bioseeker

Aberrant Notch signaling has been linked to a number of malignancies including leukemias, lymphomas and carcinomas of the breast, skin, lung, cervix and kidneys. There are today 252 companies plus partners ...

  • Industries : Biological Therapy
T Cell Receptor Signaling Pathway in Oncology Drug Pipeline Update 2014

T Cell Receptor Signaling Pathway in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • October 2014
  • by Bioseeker

Stimulation of the T cell receptor leads to the activation of NFkB and NFAT signaling modules which play a key role in T cell receptor signaling. There are today 249 companies plus partners developing ...

  • Industries : Biological Therapy
TGF-Beta Receptor Signaling Pathway in Oncology Drug Pipeline Update 2014

TGF-Beta Receptor Signaling Pathway in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • October 2014
  • by Bioseeker

The TGF-beta receptor signaling pathway activates the MAPK/SMAD signaling modules. There are today 287 companies plus partners developing 417 TGF-beta receptor pathway targeting drugs in 1514 developmental ...

  • Industries : Biological Therapy
TNF-Alpha Signaling Pathway in Oncology Drug Pipeline Update 2014

TNF-Alpha Signaling Pathway in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • October 2014
  • by Bioseeker

The TNF-alfa signaling pathway stimulates the MAPK signaling module and activates NFkB. There are today 366 companies plus partners developing 555 TNF-alpha pathway targeting drugs in 2125 developmental ...

  • Industries : Biological Therapy
Wnt Signaling Pathway in Oncology Drug Pipeline Update 2014

Wnt Signaling Pathway in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • October 2014
  • by Bioseeker

Abnormalities in the Wnt signaling pathway are associated with a large variety of human malignancies including tumors of breast, colon, pancreas, liver and bone. There are today 179 companies plus partners ...

  • Industries : Biological Therapy
Cancer Stem Cells Drug Pipeline Update 2014

Cancer Stem Cells Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • October 2014
  • by Bioseeker

Treatments designed to target and destroy cancer stem cells may come to revolutionize how we treat cancer. This unique product covers both explicit cancer stem cell drug development and cancer drugs which ...

  • Industries : Biological Therapy
Interfering With Cytokine-Cytokine Receptor Interaction for the Treatment of Cancer Drug Pipeline Update 2014

Interfering With Cytokine-Cytokine Receptor Interaction for the Treatment of Cancer Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • October 2014
  • by Bioseeker

Cytokines are soluble extracellular proteins or glycoproteins that are crucial intercellular regulators and mobilizers of cells engaged in innate as well as adaptive inflammatory host defenses, cell growth, ...

  • Industries : Biological Therapy
NeoStem, Inc. - Product Pipeline Review - 2014

NeoStem, Inc. - Product Pipeline Review - 2014

  • $ 1 500
  • Industry report
  • December 2014
  • by Global Markets Direct

NeoStem, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘NeoStem, Inc. - Product Pipeline Review - 2014', provides an overview of the NeoStem, Inc.'s pharmaceutical research and ...

  • Industries : Biological Therapy
  • Countries : World
ID Signaling Pathway in Oncology Drug Pipeline Update 2014

ID Signaling Pathway in Oncology Drug Pipeline Update 2014

  • $ 749
  • Industry report
  • October 2014
  • by Bioseeker

Inhibitor of DNA binding (ID) proteins are members of the helix-loop-helix (HLH) family of proteins which lack a DNA binding domain themselves but bind to other family members inhibiting their DNA binding ...

  • Industries : Biological Therapy

34 Companies

Read our Company Profiles

Bioheart Inc.

United States

StemCells Inc.

United States

Aastrom Biosciences Inc.

United States

Osiris Therapeutics Inc.

United States

Geron Corp.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.